Radioiodine treatment of benign thyroid diseases;A jóindulatú pajzsmirigybetegségek radiojódkezelése

Orvosi Hetilap

Volumn 147, Issue 37, 2006, Pages 1783-1789

  Konrády, András ^a  

^a Belgyógyászati Osztály és Izotóprészleg ^*  (Hungary)

Author keywords

131I; Benign thyroid disorder; Radioiodine treatment

Indexed keywords

IODINE 131; PROPYLTHIOURACIL; RADIOACTIVE IODINE; RECOMBINANT THYROTROPIN; STEROID;

DRUG CONTRAINDICATION; DRUG INDICATION; DRUG SAFETY; DRUG UPTAKE; EYE DISEASE; GOITER; GRAVES DISEASE; HUMAN; HYPOTHYROIDISM; INCIDENCE; REVIEW; THYROID CRISIS; THYROID DISEASE; THYROID FUNCTION; THYROID GLAND; THYROIDITIS; TOXIC GOITER; HYPERTHYROIDISM; NODULAR GOITER; THYROID TUMOR; TREATMENT OUTCOME;

GOITER, NODULAR; GRAVES DISEASE; HUMANS; HYPERTHYROIDISM; IODINE RADIOISOTOPES; THYROID DISEASES; THYROID NEOPLASMS; TREATMENT OUTCOME;

EID: 34748887118     PISSN: 00306002     EISSN: 17886120     Source Type: Journal    
DOI: None     Document Type: Review

References (52)

1. Albino, C. C., Mesa, C. O., Olandoski, M. és mtsai: Recombinant human thyrotropin as adjuvant in the treatment of multinodular goiters with radioiodine J. Clin. Endocrinol. Metab., 2005, 90, 2775-2780.
2. Allahabadia, A., Daykin, J., Sheppard, M. C. és mtsai: Radioiodine treatment of hyperthyroidism - prognostic factors for outcome. J. Clin. Endocrinol. Metab., 2001, 86-3617.
3. Andrade, V. A., Gross, J. L., Maia, A. L.: The effect of methimazole pretreatment on the efficacy of radioactive iodine therapy in Graves' hyperthyroidism: one year follow-up a prospective, randomized study. J. Clin. Endocrinol. Metab., 2001, 86, 3488-3493.
4. Bal, C. S., Kumar, A., Pandey, R. M.: A randomized controlled trial to evaluate the adjuvant effect of lithium on radioiodine treatment of hyperthyroidism. Thyroid, 2002, 12, 399-405.
5. Bartalena, L., Marcocci, C., Bogazzi, F. és mtsai: Relation between therapy for hyperthyroidism and the course of Graves' ophthalmopathy N. Engl. J. Med., 1998, 338, 73-78.
6. Bonnema, S. J., Bartalena, L., Toft, A. D. és mtsa: Controversies in radioiodine tharapy: relation to ophthalmopathy, the possible radioprotective effect of antithyroid drugs, and use in large goiters. Eur. J. Endocrinol., 2002, 147, 1-11.
7. 131I therapy of hyperthyroid diseases: effect on thyroid function and volume evaluated by a randomized clinical trial. Eur. J. Endocrinol., 2003, 149, 485-492.
8. Bonnema, S. J., Bennedbaek, F. N., Landenson, P. W. és mtsa: Management of the nontoxic multinodular goiter: A North American Survey. J. Clin. Endocrinol. Metab., 2002, 87, 112-117.
9. Bonnema, S. J., Bennedbaek, F. N., Wiersinga, W. M. és mtsa: Management of the nontoxic multinodular goiter: a European questionnaire study Clin. Endocrinol. (Oxf.), 2000, 53, 5-12.
10. 131I an option or not? Hot Thyroidology (ETA) (www.hotthyroidology.com) 2002. apr. No 1.
11. Burch, H. B., Solomon, B. L., Cooper, D. S. és mtsai: The effect of antithyroid drug pretreatment on acute changes in thyroid hormone levels after (131)I ablation for Graves' disease. J. Clin. Endocrinol. Metab., 2001, 86, 3016-3021.
12. Burch, H. B., Wartofsky, L.: Graves' ophthalmopathy: current concepts regarding pathogenesis and management Endocr. Rev., 1993, 14, 747-793.
13. Ceccarelli, C., Bencivelli, W., Vitti, P. és mtsai: Outcome of radioiodine-131 therapy in hyperfunctioning thyroid nodules: a 20 years' retrospective study Clin. Endocrinol., 2005, 62, 331-335.
14. Custro, N., Ganci, A., Scafidi, V.: Relapses of hyperthyroidism in patients treated with radioiodine for nodular toxic goiter: relation to thyroid autoimmunity. J. Endocrinol. Invest., 2003, 26, 106-116.
15. Dietlein, M., Dressler, J., Eschner, W. és mtsai: Procedure guideline for radioiodine test (version 2). Nuklearmedizin., 2003, 42, 116-9.
16. Dietlein, M., Schicha, H.: Basedow disease, thyroid gland autonomy, nodular goiter. When is radiotherapy indicates? MMW Fortschr. Med., 2003, 145, 47-49.
17. Dobyns, B. M., Sheline, G. E., Workman, J. B. és mtsai: Malignant and benign neoplasms of thyroid in patients treated for hyperthyroidism: a report of cooperative thyrotoxicosis therapy follow-up study. J. Clin. Endocrinol. Metab., 1974, 38, 976-998.
18. Faber, J., Galloe, A. M.: Changes in bone mass during prolonged subclinical hyperthyroidism due to L-thyroxine treatment: a meta-analysis. Eur. J. Endocr., 1994, 130, 350-356.
19. Földes J.: A radiojód terápia hazai története. In Radiojódkezelés a pajzsmirigy betegségeiben. Szerk.: Konrády, A., Szabolcs I. Offset, Vác. 1998, 13-21. o.
20. Franklyn, J. A., Sheppard, M. C., Maisonneuve, P.: Thyroid function and mortality in patients treated for hyperthyroidism. JAMA, 2005, 294, 71-80.
21. Hertz, S., Roberts, A.: Radioactive iodine in the study of thyroid physiology. VII. The use of radioactive iodine therapy in hyperthyroidism. JAMA, 1946, 131, 81 (abstr).
22. Hegedus, L., Bennedbaek, F. N.: Radioiodine for nontocix diffuse goitre. Lancet, 1997, 350, 409-410.
23. Hegedus, L., Bonnema, S. J., Bennedbaek, F. N.: Management of simple nodular goiter: current status and future perpectives. Endocr. Reviews, 2003, 24, 102-132.
24. Holm, L. E., Hall, P., Wiklund, K. és mtsai: Cancer risk after iodine- 131 therapy for hyperthyroidism. J. Natl. Cancer Inst., 1991, 83, 1072-1077.
25. Huysmans, P. A., Nieuwlaat, W., Erdtsieck, J. és mtsai: Administration of a simple low dose of recombinant human thyrotropin significantly enhanced thyroid radioiodine uptake in nontoxic nodular goiter J. Clin. Endocrinol. Metab., 2000, 85, 3592-3596.
26. Ikekubo, K., Kusakabe, K., Kanaya, S. és mtsai: The present status of I-131 therapy for Graves' hyperthyroidism in Japan. Kaku Igaku., 2003, 40, 457-463.
27. Kazakov, V. S., Demidchik, E. P., Astakova, L. N.: Thyroid cancer after Chernobyl. Nature, 1992, 359, 21-29.
28. 131I-kezelése. In: A klinikai endokrinológia és anyagcsere betegségek kézikönyve. Szerk. Leövey, A., Medicina, Budapest. 2001, 284-291. old.
29. Körber, C., Schneider, P., Körber-Hafner, N. és mtsai: Antithyroid drugs as a factor influencing the outcome of radioiodine therapy in Graves' disease and toxic nodular goiter? Eur. J. Nucl. Med., 2001, 28, 1360-1364.
30. Lind, P.: Strategies of radioiodine therapy for Graves' disease. Eur. J. Nucl. Med. Mol. Imaging., 2002, 29 (Suppl. 2.), 453-457.
31. Links, J. M.: Radiation physics. In The thyroid. 8. kiadás Szerk.: Brawerman, L. E., Utiger., R. D. Lippincott, Philadephia. 2000, 333-344. old.
32. Meller, J., Sahlman, C. O., Becker, W.: Radioiodine-treatment (RIT) of functional thyroidal autonomy. Nucl. Med. Rev. Cent. East. Eur., 2002, 5, 1-10.
33. Moka, D., Dietlein, M., Schicha, H.: Radioiodine therapy and thyrostatic drugs and iodine. Eur. J. Nucl. Med. Mol. Imaging, 2002, 29, 486-491.
34. 131 kinetics during 1311 therapy of patients with nodular goiter: an evaluation by a randomized double-blinded trial. J. Clin. Endocrinol. Metab., 2005, 90, 79-83.
35. Nielsen, V. E., Bonnema, S. J., Hegedus, L.: The effects of recombinant human thyrotropin in normal subjects and patient with goiter. Clin. Endocrinol., 2004, 61, 655-663.
36. Nieuwlaat, W. A., Hermus, A. R., Sivko-Rundelj, F. és mtsai: Pretreatment with recombinant human TSH changes the regional distribution of radioiodine on thyroid scintigrams of nodular goiters. J. Clin. Endocrinol. Metab., 2001, 86, 5330-5336.
37. Nieuwlaat, W. A., Huysmans, D. A., van den Bosch, H. C. és mtsai: Pretreatment with a single, low dose of recombinant human thyrotropin allows dose reduction of radioiodine therapy in patients with nodular goiter. J. Clin. Endocrinol. Metab., 2003, 88, 3121-3129.
38. Perros, P., Kendall-Taylor, P., Neoh, C. és mtsai: A prospective study of the effects of radioiodine therapy for hyperthyroidism in patients with minimally active Graves' ophthalmopythy J. Clin. Endocrinol. Metab., 2005, 90, 5321-5323.
39. Péter F.: A radiojód terápia indikációja gyermek és serdülokorban. In A pajzsmirigybetegségek kezelésének korszeru szemlélete. Szerk.: Konrády A., Szabolcs I. Merck, Vác, 2002, 75-85. old.
40. Policzer M., Konrády A., Szántó P. és mtsai: Lithiummal szerzett tapasztalataink a hyperthyreosis kezelésében. Izotóptechnika, 1975, 18, 818-821.
41. Reiners, C.: Radioiodine therapy for Graves' disease: problems and new developments. Z. Arztl. Fortbild. Qualitatssich., 2004, 98 (Suppl. 5.), 55-62.
42. Reinhardt, M. J., Brink, I., Joe, A. Y. és mtsai: Radioiodine therapy in Graves' disease based on tissue-absorbed dose calculations: effect of pre-treatment thyroid volume on clinical outcome. Eur. J. Nucl. Med., 2002, 29, 1118-1124.
43. Rivkees, S. A., Sklar, C., Freemark, M.: The management of Graves' disease in children with special emphasis on radioiodine treatment J. Clin. Endocrinol. Metab. (Clinical Review 99.), 1998, 83, 3767-3776.
44. 131I -therapy in Graves disease. Nucl. Med. Rev. Cent. East Eur., 2004, 7, 117-22.
45. Ron, E., Doody, M. M., Becker, D. V. és mtsai: For the Cooperative Thyrotoxicosis Therapy Follow-up Study Group: Cancer mortality following treatment for adult hyperthyroidism. JAMA, 1998, 280, 347-355.
46. Santos, R. B., Romaldini, J. H., Ward, L. S.: Propylthiouracil reduces the efectiveness of radioiodine treatment in hyperthyroid patients with Graves' disease. Thyroid, 2004, 14, 525-530.
47. Sawin, C. T., Becker, D. V.: Radioidine and the treatment of hyperthyroidism: the early history. Thyroid, 1997, 7, 163-176.
48. Sawin, C. T., Geller, A., Wolf, P. A. és mtsai: Low serum thyrotropin concentrations as a risk factor for atrial fibrillation in older persons N. Engl. J. Med., 1994, 331, 1249-1252.
49. Schicha, H., Dietlein, M.: Graves' disease and toxic nodular goiter - radioiodine therapy Nuklear-medizin, 2002, 41, 63-70.
50. Urbannek, V., Vot, E., Moka, D. és mtsa: Radioiodine therapy of Graves' disease - and dosimetric comparison of various therapy regimens of antithyroid agents. Nuklearmedizin, 2001, 40, 111-115.
51. Wallaschofski, H., Muller, D., Georgi, P. és mtsai: Induction of TSH-receptor antibodies in patients with toxic multinodular goiter by radioiodine treatment. Horm. Metab. Res., 2002, 34, 36-39.
52. Wang, C. Y. Chang, T. J., Chang, T. C. és mtsai: Thyroidectomy or radioiodine? The value of ultrasonography and cytology in the assessment of nodular lesions in Graves' hyperthyroidism. Am. Surg., 2001, 67, 721-726.